Literature DB >> 28524854

A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium.

Nuria Eritja1,2, Isidre Felip1, Mari Alba Dosil1,2, Lucia Vigezzi3, Cristina Mirantes1, Andree Yeramian1,2, Raúl Navaridas1, Maria Santacana1,2, David Llobet-Navas4, Akihiko Yoshimura5, Masatoshi Nomura6, Mario Encinas7, Xavier Matias-Guiu1,2, Xavi Dolcet1,2.   

Abstract

The TGF-β/Smad and the PI3K/AKT signaling pathways are important regulators of proliferation and apoptosis, and their alterations lead to cancer development. TGF-β acts as a tumor suppressor in premalignant cells, but it is a tumor promoter for cancerous cells. Such dichotomous actions are dictated by different cellular contexts. Here, we have unveiled a PTEN-Smad3 regulatory loop that provides a new insight in the complex cross talk between TGF-β/Smad and PI3K/AKT signaling pathways. We demonstrate that TGF-β triggers apoptosis of wild-type polarized endometrial epithelial cells by a Smad3-dependent activation of PTEN transcription, which results in the inhibition of PI3K/AKT signaling pathway. We show that specific Smad3 knockdown or knockout reduces basal and TGF-β-induced PTEN expression in endometrial cells, resulting in a blockade of TGF-β-induced apoptosis and an enhancement of cell proliferation. Likewise Smad3 deletion, PTEN knockout prevents TGF-β-induced apoptosis and increases cell proliferation by increasing PI3K/AKT/mTOR signaling. In summary, our results demonstrate that Smad3-PTEN signaling axis determine cellular responses to TGF-β.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28524854      PMCID: PMC5520461          DOI: 10.1038/cdd.2017.73

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  44 in total

1.  Smad3 potentiates transforming growth factor beta (TGFbeta )-induced apoptosis and expression of the BH3-only protein Bim in WEHI 231 B lymphocytes.

Authors:  Gary M Wildey; Supriya Patil; Philip H Howe
Journal:  J Biol Chem       Date:  2003-03-13       Impact factor: 5.157

2.  Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways.

Authors:  Yuki Sugiyama; Kyosuke Kakoi; Akihiro Kimura; Ichiro Takada; Ikko Kashiwagi; Yu Wakabayashi; Rimpei Morita; Masatoshi Nomura; Akihiko Yoshimura
Journal:  Int Immunol       Date:  2012-02-13       Impact factor: 4.823

Review 3.  Smad transcription factors.

Authors:  Joan Massagué; Joan Seoane; David Wotton
Journal:  Genes Dev       Date:  2005-12-01       Impact factor: 11.361

Review 4.  A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.

Authors:  Kimberly A Brown; Jennifer A Pietenpol; Harold L Moses
Journal:  J Cell Biochem       Date:  2007-05-01       Impact factor: 4.429

Review 5.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

6.  Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer.

Authors:  Joshua Kesterson; Dan Wang; Paulette Mhawech-Fauceglia; Stacey Akers; Nefertiti Chianti DuPont; Kimberly Clark; Shashikant Lele; Song Liu
Journal:  Histopathology       Date:  2011-07       Impact factor: 5.087

Review 7.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

Review 8.  Roles of TGFbeta in metastasis.

Authors:  David Padua; Joan Massagué
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

Review 9.  TGF-beta-induced epithelial to mesenchymal transition.

Authors:  Jian Xu; Samy Lamouille; Rik Derynck
Journal:  Cell Res       Date:  2009-02       Impact factor: 25.617

Review 10.  Transforming growth factor β signaling in uterine development and function.

Authors:  Qinglei Li
Journal:  J Anim Sci Biotechnol       Date:  2014-11-14
View more
  9 in total

1.  The Estrogen Receptor α Cistrome in Human Endometrium and Epithelial Organoids.

Authors:  Sylvia C Hewitt; San-Pin Wu; Tianyuan Wang; Madhumita Ray; Marja Brolinson; Steven L Young; Thomas E Spencer; Alan DeCherney; Francesco J DeMayo
Journal:  Endocrinology       Date:  2022-09-01       Impact factor: 5.051

2.  Identification of lncRNAs associated with lung squamous cell carcinoma prognosis in the competitive endogenous RNA network.

Authors:  Lingyu Qi; Tingting Zhang; Yan Yao; Jing Zhuang; Cun Liu; Ruijuan Liu; Changgang Sun
Journal:  PeerJ       Date:  2019-09-17       Impact factor: 2.984

3.  ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

Authors:  Cristina Megino-Luque; Pol Sisó; Natalia Mota-Martorell; Raúl Navaridas; Inés de la Rosa; Izaskun Urdanibia; Manel Albertí-Valls; Maria Santacana; Miquel Pinyol; Núria Bonifaci; Anna Macià; David Llobet-Navas; Sònia Gatius; Xavier Matias-Guiu; Núria Eritja
Journal:  Mol Oncol       Date:  2022-03-02       Impact factor: 7.449

Review 4.  The Role of PTEN in Epithelial-Mesenchymal Transition.

Authors:  Olga Fedorova; Sergey Parfenyev; Alexandra Daks; Oleg Shuvalov; Nickolai A Barlev
Journal:  Cancers (Basel)       Date:  2022-08-03       Impact factor: 6.575

5.  Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition.

Authors:  Anna Ruiz-Mitjana; Raúl Navaridas; Maria Vidal-Sabanés; Aida Perramon-Güell; Andree Yeramian; Isidre Felip; Núria Eritja; Joaquim Egea; Mario Encinas; Xavier Matias-Guiu; Xavier Dolcet
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

6.  BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity.

Authors:  Junxiu Liu; Tian Tian; Xiangyu Liu; Zhumei Cui
Journal:  J Immunol Res       Date:  2022-07-21       Impact factor: 4.493

7.  NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway.

Authors:  Xiao-Feng Yin; Qiong Zhang; Zhuo-Yu Chen; Hai-Fang Wang; Xin Li; Hong-Xia Wang; Hai-Xia Li; Chun-Min Kang; Shuai Chu; Kai-Fei Li; Yao Li; Yu-Rong Qiu
Journal:  Int J Oncol       Date:  2018-07-12       Impact factor: 5.650

8.  Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming.

Authors:  Yohan Suryo Rahmanto; Wenjing Shen; Xu Shi; Xi Chen; Yu Yu; Zheng-Cheng Yu; Tsutomu Miyamoto; Meng-Horng Lee; Vivek Singh; Ryoichi Asaka; Geoffrey Shimberg; Michele I Vitolo; Stuart S Martin; Denis Wirtz; Ronny Drapkin; Jianhua Xuan; Tian-Li Wang; Ie-Ming Shih
Journal:  Nat Commun       Date:  2020-06-01       Impact factor: 14.919

9.  The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten.

Authors:  Xiaohuan Liang; Takiko Daikoku; Jumpei Terakawa; Yuya Ogawa; Ayesha R Joshi; Lora H Ellenson; Xiaofei Sun; Sudhansu K Dey
Journal:  PLoS Genet       Date:  2018-08-24       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.